Works by Kang, Mingyi

Results: 8

Empathy in Chinese eight-year medical program students: differences by school year, educational stage, and future career preference.

Published in:

BMC Medical Education, 2018, v. 18, n. 1, p. N.PAG, doi. 10.1186/s12909-018-1348-2

By:

Li, Dongju;
Xu, Huiming;
Kang, Mingyi;
Ma, Shulan

Publication type:

Article

An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer.

Published in:

2022

By:

Xu, Jing;
Gao, Yi;
Luan, Xiaotian;
Li, Ke;
Wang, Jing;
Dai, Yilin;
Kang, Mingyi;
Lu, Chong;
Zhang, Minhua;
Lu, Chris X.;
Kang, Yu;
Xu, Congjian

Publication type:

journal article

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type.

Published in:

Journal of Ovarian Research, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13048-025-01649-8

By:

Gao, Yi;
Zheng, Kewei;
Tan, Haowen;
Kang, Mingyi;
Lu, Bingjian;
Chen, Ling;
Xu, Jing;
Lu, Chong;
Chai, Ranran;
Xu, Congjian;
Kang, Yu

Publication type:

Article

Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type.

Published in:

Human Cell, 2023, v. 36, n. 6, p. 2214, doi. 10.1007/s13577-023-00966-8

By:

Gao, Yi;
Zheng, Kewei;
Kang, Mingyi;
Xu, Jing;
Ning, Yan;
Hu, Weiguo;
Li, Ke;
Kang, Yu;
Xu, Congjian

Publication type:

Article

A comparative study of two thienopyrimidine Schiff base probes for sequential monitoring of Ga3+ and Pd2+.

Published in:

Luminescence: Journal of Biological & Chemical Luminescence, 2024, v. 39, n. 5, p. 1, doi. 10.1002/bio.4773

By:

Shi, Manman;
Li, Boli;
Kang, Mingyi;
Liu, Peng;
Yang, Xiaofeng;
Pei, Meishan;
Zhang, Guangyou

Publication type:

Article

Thienopyrimidine‐derived multifunctional fluorescence sensor for the detection of Cu2+, Fe3+, and PPi in different solvents.

Published in:

Luminescence: Journal of Biological & Chemical Luminescence, 2024, v. 39, n. 5, p. 1, doi. 10.1002/bio.4744

By:

Shi, Manman;
Kang, Mingyi;
Liu, Peng;
Zhou, Han;
Pei, Meishan;
Zhang, Guangyou;
Yang, Xiaofeng

Publication type:

Article

A multi-institutional and cross-sectional study on empathy in Chinese medical students: differences by student cadre or not, future career preference, and father's education status.

Published in:

BMC Medical Education, 2020, v. 20, n. 1, p. 1, doi. 10.1186/s12909-020-1935-x

By:

Yi, Kangqi;
Kang, Mingyi;
Li, Dongju;
Wang, Zhipeng;
Bai, Jinsong;
Xu, Huiming;
Ma, Shulan

Publication type:

Article

mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin.

Published in:

Biomedicines, 2025, v. 13, n. 1, p. 1, doi. 10.3390/biomedicines13010001

By:

Zheng, Kewei;
Gao, Yi;
Xu, Jing;
Kang, Mingyi;
Chai, Ranran;
Jin, Guanqin;
Kang, Yu

Publication type:

Article

Works by Kang, Mingyi

Empathy in Chinese eight-year medical program students: differences by school year, educational stage, and future career preference.

An effective AKT inhibitor-PARP inhibitor combination therapy for recurrent ovarian cancer.

Single-cell RNA sequencing reveals the intra-tumoral heterogeneity and immune microenvironment of small cell carcinoma of the ovary, hypercalcemic type.

Establishment and characterization of a novel cell line (SCCOHT-CH-1) and PDX models derived from Chinese patients of small cell ovarian carcinoma of the hypercalcemic type.

A comparative study of two thienopyrimidine Schiff base probes for sequential monitoring of Ga<sup>3+</sup> and Pd<sup>2+</sup>.

Thienopyrimidine‐derived multifunctional fluorescence sensor for the detection of Cu<sup>2+</sup>, Fe<sup>3+</sup>, and PPi in different solvents.

A multi-institutional and cross-sectional study on empathy in Chinese medical students: differences by student cadre or not, future career preference, and father's education status.

mTOR Inhibitor Everolimus Modulates Tumor Growth in Small-Cell Carcinoma of the Ovary, Hypercalcemic Type and Augments the Drug Sensitivity of Cancer Cells to Cisplatin.